首页> 外国专利> Method of treating Rett syndrome by oral administration of acetate which is provided as composition comprising magnesium acetate, calcium acetate or ethylacetate

Method of treating Rett syndrome by oral administration of acetate which is provided as composition comprising magnesium acetate, calcium acetate or ethylacetate

机译:通过口服施用乙酸盐治疗Rett综合征的方法,所述乙酸盐作为包含乙酸镁,乙酸钙或乙酸乙酯的组合物提供

摘要

Genetic and epigenetic diseases and disorders are treated with FDA approved dietary compositions in the form of dietary supplements and nutraceuticals. The diseases and disorders to be treated include Rett syndrome, trinucleotide repeat diseases such as Fragile X syndrome, memory impairment, chronic inflammation, pre-cancerous conditions which involve cancer stem cells, and post-cancerous conditions which involve cancer stem cells which have survived in spite of cancer treatment. Treatment options include prophylactic treatment which is initiated prior to the development of the symptoms of the disease or disorder.
机译:遗传和表观遗传疾病和病症可以通过FDA批准的膳食补充剂和营养保健品形式的饮食组合物进行治疗。待治疗的疾病和失调包括Rett综合征,三核苷酸重复疾病(如脆性X综合征),记忆力减退,慢性炎症,涉及癌干细胞的癌前病况以及涉及在癌症中存活的癌干细胞的癌后病况。尽管接受了癌症治疗。治疗选择包括在疾病或病症的症状发展之前开始的预防性治疗。

著录项

  • 公开/公告号US9968580B2

    专利类型

  • 公开/公告日2018-05-15

    原文格式PDF

  • 申请/专利权人 DAVID MICHAEL OTT;

    申请/专利号US201615251880

  • 发明设计人 DAVID MICHAEL OTT;

    申请日2016-08-30

  • 分类号A61K31/32;A23L33/10;A61K31/19;A61K31/22;

  • 国家 US

  • 入库时间 2022-08-21 13:00:15

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号